|
ARPC5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.71429999979078E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.82190000033822E-07 |
| Normal-vs-Stage2 |
7.19310000452111E-08 |
| Normal-vs-Stage3 |
7.775800E-04 |
| Normal-vs-Stage4 |
1.375460E-03 |
| Stage1-vs-Stage2 |
7.284000E-03 |
| Stage1-vs-Stage3 |
5.337200E-01 |
| Stage1-vs-Stage4 |
8.317400E-01 |
| Stage2-vs-Stage3 |
1.418210E-02 |
| Stage2-vs-Stage4 |
1.296200E-01 |
| Stage3-vs-Stage4 |
5.619800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.76690000000634E-06 |
| Normal-vs-AfricanAmerican |
2.522000E-01 |
| Normal-vs-Asian |
8.17300000000021E-05 |
| Caucasian-vs-AfricanAmerican |
5.854300E-02 |
| Caucasian-vs-Asian |
5.830400E-01 |
| AfricanAmerican-vs-Asian |
4.208000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.5257999999987E-05 |
| Normal-vs-Female |
2.76089999973195E-07 |
| Male-vs-Female |
4.066400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.21849999999724E-05 |
| Normal-vs-Age(41-60Yrs) |
5.12849995804032E-09 |
| Normal-vs-Age(61-80Yrs) |
2.557600E-04 |
| Normal-vs-Age(81-100Yrs) |
9.400600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.515560E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.107600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.122100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.973400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.939000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.254300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.586800E-01 |
| Classical-VS-Follicular |
7.118400E-02 |
| Classical-VS-Other |
3.551800E-01 |
| Classical-VS-Normal |
1.53768999999748E-05 |
| Tall-VS-Follicular |
1.584840E-01 |
| Tall-VS-Other |
3.710200E-01 |
| Tall-VS-Normal |
2.046300E-02 |
| Follicular-VS-Other |
7.324800E-01 |
| Follicular-VS-Normal |
2.93950000007648E-07 |
| Other-VS-Normal |
1.199600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.31209995593673E-09 |
| Normal-vs-N1 |
7.85040000000903E-05 |
| N0-vs-N1 |
7.719200E-01 |
|
|
